Functional changes in gut microbiota during hematopoietic stem cell transplantation for severe combined immunodeficiency  Jonathan P. Lane, MBBS, Christopher.

Slides:



Advertisements
Similar presentations
Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
Advertisements

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.
Induced pluripotent stem cells: A novel frontier in the study of human primary immunodeficiencies Itai M. Pessach, MD, PhD, Jose Ordovas-Montanes, BA,
D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Risk of an asthma exacerbation after bariatric surgery in adults
Fatty acids, inflammation, and asthma
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning  Niraj.
Fatty acids, inflammation, and asthma
Joe K. Gerald, MD, PhD, Roni Grad, MD, William C. Bailey, MD, Lynn B
Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency  Evelina Mazzolari, MD, Concetta.
Rising prevalence of asthma is sex-specific in a US farming population
Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations  Keita Hirai, PhD, Toshihiro Shirai, MD, PhD, Masayuki Suzuki,
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Allergy testing in predicting outcome of open food challenge to peanut
The National Biome Initiative: An allergy perspective
Physician needs in health informatics: Just ask the docs
Outcome of domino hematopoietic stem cell transplantation in human subjects: An international case series  Mirjam E. Belderbos, MD, PhD, Andrew R. Gennery,
Gut microbiome variations during hematopoietic stem cell transplant in severe combined immunodeficiency  Jonathan P. Lane, MBBS, Christopher J. Stewart,
Peter M. Wolfgram, MD, David B. Allen, MD 
Etiology of asthma exacerbations
The future of allergy/immunology: Promising young investigators
William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P
An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1– related disease in children  Kumud K. Singh, PhD, Alexis Lieser, MD,
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Respiratory sensitization of a worker to the warehouse beetle Trogoderma variabile: An index case report  Jonathan A. Bernstein, MD, Marjorie S. Morgan,
Low diversity of the gut microbiota in infants with atopic eczema
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Food allergy in patients with primary immunodeficiency diseases: Prevalence within the US Immunodeficiency Network (USIDNET)  Karen S. Tuano, MD, Jordan.
What are the best outcome measurements for atopic eczema
Atopic dermatitis: A practice parameter update 2012
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity  Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,
Lisa G. Wood, PhD, Manohar L. Garg, PhD, Peter G. Gibson, MBBS 
What is an “eosinophilic phenotype” of asthma?
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Geographic variability in childhood asthma prevalence in Chicago
New pathways for itching in patients with atopic dermatitis?
Prevention of food allergy: Beyond peanut
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
Biology of nasal polyposis
Machine learning, natural language programming, and electronic health records: The next step in the artificial intelligence journey?  Neil Mehta, MBBS,
Jessica H. Savage, MD, MHS, Elizabeth C. Matsui, MD, MHS, Robert A
Measles and immunomodulation
The Editors' Choice Journal of Allergy and Clinical Immunology
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Severe cutaneous human papillomavirus infection associated with natural killer cell deficiency following stem cell transplantation for severe combined.
Environmental factors and eosinophilic esophagitis
Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts  Helen Chapel, MA,
Safety and efficacy of repeated monthly carboplatin desensitization
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Itching as a systemic disease
Liver disease predicts mortality in patients with X-linked immunodeficiency with hyper- IgM but can be prevented by early hematopoietic stem cell transplantation 
Presentation transcript:

Functional changes in gut microbiota during hematopoietic stem cell transplantation for severe combined immunodeficiency  Jonathan P. Lane, MBBS, Christopher J. Stewart, PhD, Stephen P. Cummings, PhD, Andrew R. Gennery, MD  Journal of Allergy and Clinical Immunology  Volume 138, Issue 2, Pages 622-625.e3 (August 2016) DOI: 10.1016/j.jaci.2016.02.019 Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 PLS-DA showing separation of metabolite profiles by pre- or post-HSCT status. X/Y overview values for pre- and post-HSCT: R2 = 0.77, Q2 = 0.6; values >0.5 demonstrate data passes validation and are robust and reproducibly predictive of pre- and post-HSCT grouping. Journal of Allergy and Clinical Immunology 2016 138, 622-625.e3DOI: (10.1016/j.jaci.2016.02.019) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Level 2 PICRUSt (phylogenetic investigation of communities by reconstruction of unobserved states) analysis for patients A (A), B (B), and D (C). T (blue)—day of HSCT. N (green)—neutrophil engraftment. Conditioning (yellow): Treo/flu/C1H—treosulfan, fludarabine, Campath. Antibiotics (black): T—teicoplanin; M—meropenem; S—co-trimoxazole; C—ceftazidime; V—vancomycin; A—amikacin; Aug—co-amoxiclav. Clinically significant complications noted (orange). Journal of Allergy and Clinical Immunology 2016 138, 622-625.e3DOI: (10.1016/j.jaci.2016.02.019) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 Level 3 PICRUSt (phylogenetic investigation of communities by reconstruction of unobserved states) analysis for bacterial cell motility expression (A-C) and membrane transport expression (D-E) for patients A, B, and D. T (blue)—day of HSCT. N (green)—day of neutrophil engraftment. Conditioning (yellow): Treo/flu/C1H—treosulfan, fludarabine, Campath. Antibiotics (black): T—teicoplanin; M—meropenem; S—co-trimoxazole; C—ceftazidime; V—vancomycin; A—amikacin; Aug—co-amoxiclav. Clinically significant complications noted (orange). Journal of Allergy and Clinical Immunology 2016 138, 622-625.e3DOI: (10.1016/j.jaci.2016.02.019) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions